Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01192438 · ClinicalTrials.gov registry record · NA
Laser Based Focal Ablation of Low Grade Prostate Cancer
A NA study of Low Grade Prostate Cancer, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
- 1
- Study location
NCT01192438 is a NA study of Low Grade Prostate Cancer that has completed, run by University of Chicago. The registered enrollment target is 9 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01192438, a NA study of Low Grade Prostate Cancer, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the safety of MRI-guided laser-induced thermal therapy of biopsy confirmed low-risk prostate cancer.
Conditions Studied
Interventions
- PROCEDURE Laser-based thermotherapy
Study Locations (1)
Illinois
- University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2010-01 |
| Est. Completion | 2011-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01192438
The ClinicalTrials.gov registry entry for NCT01192438 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Low Grade Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Laser-based thermotherapy is the first listed.
NCT01192438 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT01192438 about?
NCT01192438 is a clinical study titled "Laser Based Focal Ablation of Low Grade Prostate Cancer". The purpose of this study is to evaluate the safety of MRI-guided laser-induced thermal therapy of biopsy confirmed low-risk prostate cancer.
What is the current status of trial NCT01192438?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2010-01. Estimated completion is 2011-09.
What conditions does trial NCT01192438 study?
This clinical trial studies the following conditions: Low Grade Prostate Cancer.
What interventions are being tested in trial NCT01192438?
The interventions under investigation include: Laser-based thermotherapy (PROCEDURE).
Who is sponsoring clinical trial NCT01192438?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01192438 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.